Mind-NRG
Latest round
- Series B
Last raised
- Sep 2013
Total raised
- $11M
Investors
- 2
About Mind-NRG
Founded in 2010, based in Switzerland, Mind-NRG is focused on the development of neurological and psychiatric disorders. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood - brain barrier through a receptor-mediated transport to reach its target in the brain.
Who invested in Mind-NRG
2 investors across 3 rounds
See all investors in Mind-NRG
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mind-NRG
Who invested in Mind-NRG?
Mind-NRG has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mind-NRG raised?
Mind-NRG has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mind-NRG last raise money?
Mind-NRG's most recent round on record is a Series B, in Sep 2013.
What does Mind-NRG do?
Founded in 2010, based in Switzerland, Mind-NRG is focused on the development of neurological and psychiatric disorders.
Where is Mind-NRG headquartered?
Mind-NRG is headquartered in Geneva, Switzerland.
Which VCs invest in companies like Mind-NRG?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Mind-NRG's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Mind-NRG? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.